参考文献/References:
[1] 黄光明.理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究[J].陕西中医,2021,42(2):159-162.
[2] 李 刚,陈紫凡.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321-1324.
[3] 金爱萍,李 蔚,李 冰,等.AMP激活蛋白激酶对慢性心力衰竭进展影响的实验研究[J].陕西医学杂志,2021,50(1):3-6.
[4] 种冠峰,李伟国,王秀红,等.慢型克山病患者左室射血分数恢复正常的预测因素研究[J].中华地方病学杂志,2021,40(4):273-278.
[5] 吕亚囡,王雪梅,徐 哲,等.基于心脏磁共振心功能分析定量评价未识别心肌梗塞合并心力衰竭的初步临床研究[J].黑龙江医药科学,2021,44(1):21-23.
[6] 吕小波,郜长江,胡洪磊.血浆miR-26b表达鉴别诊断急性呼吸窘迫综合征和急性心力衰竭的临床价值[J].中西医结合心脑血管病杂志,2021,19(5):804-807.
[7] Suceveanu AP,Shokoples BG,Paradis P,et al.P2X7 Receptors:An untapped target for the management of cardiovascular disease[J].Metabolites,2021,41(1):186-199.
[8] 马 秀,戴 晨,张源明.核苷酸结合寡聚化结构域样受体蛋白3炎症小体与髙血压病的研究进展[J].心血管病学进展,2018,39(2):198-201.
[9] Zeng C,Wang R,Tan H.Role of Pyroptosis in cardiovascular diseases and its therapeutic implications[J].Int J Biol Sci,2019,15(7):1345-1357.
[10] 李丽君,王 晶,耿晓雯,等.应用左心室舒张末容积校正的QRS持续时间对心脏同步化治疗的预测作用[J].中国心血管病研究,2021,19(2):134-137.
[11] Butts B,Gary RA,Dunbar SB,et al.The importance of NLRP3 inflammasome in heart failure[J].J Card Fail,2015,21(7):586-593.
[12] Jaen RI,Val-Blasco A,Prieto P,et al.Innate immune receptors,key actors in cardiovascular diseases[J].JACC Basic Transl Sci,2020,5(7):735-749.
[13] Keshavarz-Bahaghighat H,Darwesh AM,Sosnowski DK,et al.Mitochondrial dysfunction and inflammaging in heart failure:Novel roles of CYP-Derived epoxylipids[J].Cells,2020,9(7):114-119.
[14] 罗 猛,刘 洋,杨添添,等.心肌淀粉样变性患者的临床特征及预后分析[J].中国循环杂志,2021,36(4):367-371.
[15] Lopaschuk GD,Verma S.Mechanisms of cardiovascular benefits of sodium glucose Co-Transporter 2(SGLT2)inhibitors:A state-of-the-art review[J].J Immunol Res,2020,5(6):632-644.
[16] Mezzaroma E,Abbate A,Toldo S.NLRP3 inflammasome inhibitors in cardiovascular diseases[J].Molecules,2021,26(4):224-229.
[17] Sharma A,Tate M,Mathew G,et al.Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications:Therapeutic implications[J].Front Physiol,2018,9(12):114.
[18] Zuurbier CJ,Abbate A,Cabrera-Fuentes HA,et al.Innate immunity as a target for acute cardioprotection[J].Clin Transl Med,2019,115(7):1131-1142.
[19] 王元芬,詹 鹏,黄 青,等.老年心力衰竭患者心电异常活动程度与左心室心肌收缩功能的相关性[J].中国老年学杂志,2021,41(4):696-698.
[20] 王建宾,王丽莉,杨会娟.老年重症心力衰竭患者住院期间病死率的影响因素[J].中国老年学杂志,2021,41(7):1359-1362.
相似文献/References:
[1]周岩芬,张敏,周万保,等.NT-proBNP、肥胖及心力衰竭风险之间的相关性研究[J].陕西医学杂志,2016,(09):1163.
[2]张敏,张科林.托拉塞米联合多巴胺对老年顽固性心衰疗效及脑钠肽的影响[J].陕西医学杂志,2016,(09):1226.
[3]熊三军,马江伟,乔增勇.重组人脑利钠肽治疗心力衰竭临床效果及对患者尿量、心功能、炎症指标的影响[J].陕西医学杂志,2019,(1):99.
[4]倪凤扬,姬新才,吴可君,等.慢性心力衰竭患者血清胱抑素Ｃ水平与抑郁障碍相关性分析*[J].陕西医学杂志,2019,(4):425.
NI Fengyang,JI Xincai,WU Kejun,et al.The qssociation between Cystatin C and depression in patients with chronic heart failure[J].,2019,(1):425.
[5]龙继贤,高文妹.ST段抬高型急性心肌梗死早期脑钠肽水平变化及各个时间点检测对心力衰竭的诊断价值[J].陕西医学杂志,2019,(5):595.
LONG Jixian,GAO Wenmei..The change of brain natriuretic peptide(BNP)concentration in the early stage of STsegment elevationacute myocardial infarction and the diagnostic value of BNP at different time points for heart failure at that time[J].,2019,(1):595.
[6]王 颖,马思蕊,何 旭△.替米沙坦联合培哚普利治疗心力衰竭疗效及对患者左心室射血分数的影响[J].陕西医学杂志,2019,(8):1066.
WANG Ying,MA Sirui,HE Xu..Efficacy of telmisartan combined with perindopril in the treatment of heart failure and its
effect on left ventricular ejection fraction in patients[J].,2019,(1):1066.
[7]赵秀娟,雷晓慧.缩短分数、等容收缩时间等超声指标对异丙肾上腺素诱导的大鼠心肌损伤诊断价值研究[J].陕西医学杂志,2021,50(10):1179.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.001]
ZHAO Xiujuan,LEI Xiaohui.Diagnostic value of fraction shortening,iso volumetric contraction time and other ultrasound indicators in rats with isoprenaline-induced heart injury[J].,2021,50(1):1179.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.001]
[8]张静雯,王 利,赵 敏,等.核苷酸结合寡聚化结构域样受体蛋白3介导细胞焦亡在痛风性关节炎中的作用机制研究[J].陕西医学杂志,2022,51(5):561.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.011]
ZHANG Jingwen,WANG Li,ZHAO Min,et al.Mechanism of NLRP3 inflammasome-mediated pyroptosis in acute gouty arthritis[J].,2022,51(1):561.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.011]
[9]韩 媛,曾新春.半乳糖凝集素-3抑制剂柑橘果胶对心力衰竭大鼠血浆N端B型利钠肽原及心肌纤维化的影响[J].陕西医学杂志,2022,51(6):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]
HAN Yuan,ZENG Xinchun.Effects of Galectin-3 inhibitor citrus pectin on NT-proBNP and myocardial fibrosis in heart failure rats[J].,2022,51(1):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]
[10]张 娅,张 洁.心肌胰岛素抵抗致心力衰竭研究进展[J].陕西医学杂志,2023,52(4):495.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.030]